AU9269898A - Artificial viruses derived from papillomavirus, and their uses, in particular gene therapy - Google Patents

Artificial viruses derived from papillomavirus, and their uses, in particular gene therapy

Info

Publication number
AU9269898A
AU9269898A AU92698/98A AU9269898A AU9269898A AU 9269898 A AU9269898 A AU 9269898A AU 92698/98 A AU92698/98 A AU 92698/98A AU 9269898 A AU9269898 A AU 9269898A AU 9269898 A AU9269898 A AU 9269898A
Authority
AU
Australia
Prior art keywords
papillomavirus
gene therapy
particular gene
viruses derived
artificial viruses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU92698/98A
Inventor
Pierre Coursaget
Antoine Touze
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Publication of AU9269898A publication Critical patent/AU9269898A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20023—Virus like particles [VLP]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU92698/98A 1997-09-22 1998-09-22 Artificial viruses derived from papillomavirus, and their uses, in particular gene therapy Abandoned AU9269898A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9711772A FR2768749A1 (en) 1997-09-22 1997-09-22 Papillomavirus virus-like particles
FR9711772 1997-09-22
PCT/FR1998/002029 WO1999015630A1 (en) 1997-09-22 1998-09-22 Artificial viruses derived from papillomavirus, and their uses, in particular gene therapy

Publications (1)

Publication Number Publication Date
AU9269898A true AU9269898A (en) 1999-04-12

Family

ID=9511336

Family Applications (1)

Application Number Title Priority Date Filing Date
AU92698/98A Abandoned AU9269898A (en) 1997-09-22 1998-09-22 Artificial viruses derived from papillomavirus, and their uses, in particular gene therapy

Country Status (3)

Country Link
AU (1) AU9269898A (en)
FR (1) FR2768749A1 (en)
WO (1) WO1999015630A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1015561B1 (en) * 1997-09-05 2006-07-19 Medimmune, Inc. In vitro method for disassembly/reassembly of papillomavirus virus-like particles (vlps)
SE514982C2 (en) * 1999-09-30 2001-05-28 Active Biotech Ab Carrier containing a major capsid protein L1 from human papillomavirus and its use
CA2875298A1 (en) * 1999-12-09 2001-06-14 Medimmune, Inc. In vitro method for disassembly/reassembly of papillomavirus virus-like particles (vlps)
JP5196786B2 (en) 2003-10-31 2013-05-15 サンシャイン・ハート・カンパニー・ピーティーワイ・リミテッド Synchronous control system
US8778351B2 (en) 2006-08-30 2014-07-15 University Of Rochester Combined human papillomavirus VLP/gene delivery system and use thereof as a vaccine for prophylaxis and immunotherapy of infectious diseases and tumors
ES2845212T3 (en) * 2009-04-13 2021-07-26 Inst Nat Sante Rech Med HPV particles and their uses
EP2407534A1 (en) 2010-07-14 2012-01-18 Neo Virnatech, S.L. Methods and reagents for obtaining transcriptionally active virus-like particles and recombinant virions
US9700639B2 (en) 2012-02-07 2017-07-11 Aura Biosciences, Inc. Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells
ES2729841T3 (en) 2013-09-18 2019-11-06 Aura Biosciences Inc Conjugates of virus-like particles to treat tumors
MX2018005468A (en) 2015-10-30 2018-11-09 The Us Secretary Department Of Health And Man Services Targeted cancer therapy.
FR3110395A1 (en) 2020-05-20 2021-11-26 M.G.B. Pharma A composition comprising a metal ascorbocamphorate compound for use in the treatment of infections caused by papillomavirus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992016638A1 (en) * 1991-03-14 1992-10-01 5 Prime --> 3 Prime, Inc. Transduction vehicles for transferring dna to a mammalian cell
IL115880A (en) * 1995-11-06 2008-11-26 Hadasit Med Res Service Construct for infecting mammalian cells comprising the sv40 vp1 capsid protein and a histone - free constituent, methods of construction and uses thereof
FR2749323B1 (en) * 1996-06-04 1998-07-10 Pasteur Merieux Serums Vacc PSEUDO-PARTICLES VIRALES USEFUL AS A VECTOR OF NUCLEIC ACID DELIVERY

Also Published As

Publication number Publication date
FR2768749A1 (en) 1999-03-26
WO1999015630A1 (en) 1999-04-01

Similar Documents

Publication Publication Date Title
AU2086199A (en) Plant uridine diphosphate-glucose dehydrogenase genes, proteins, and uses thereof
EP0710667B8 (en) Modified oligonucleotides, their preparation and their use
AU4095999A (en) Cell cycle genes, proteins and uses thereof
AU1102399A (en) Human tumor necrosis factor receptor-like proteins tr11, tr11sv1, and tr11sv2
AU2572499A (en) Human hairless gene, protein and uses thereof
AU9633098A (en) Benzoxazine derivatives, preparation and application in therapy
AU9269898A (en) Artificial viruses derived from papillomavirus, and their uses, in particular gene therapy
AU7748200A (en) Hypoxia-related human genes, proteins, and uses thereof
AU7261898A (en) Methods for viral inactivation and compositions for use in same
CA2278808A1 (en) Methods for cultivating cells and propagating viruses
AU3072500A (en) Rhamnosyl-transferase gene and uses thereof
AU2418499A (en) Org-5222 in the treatment of depression
HUP0104825A3 (en) Genes and proteins, and their use
AU5008296A (en) Recombinant viruses expressing lecithin-cholesterol acyltransferase, and uses thereof in gene therapy
AU9569998A (en) Photo-spectrometers, methods of use and manufacture
AU6962698A (en) Transgenomic viruses and the use thereof
AU3860100A (en) Human tumor necrosis factor receptor-like proteins tr11, tr11sv1, and tr11sv2
AU1944799A (en) Hyperhydrated citicoline, process and use
AUPP617598A0 (en) Genetic sequence and uses therefor
AU3262697A (en) Combinations comprising vx478, zidovudine and/or 1592u89 for use in the treatment of hiv
IL112992A0 (en) Recombinant viruses, their preparation and their use in gene therapy
AU7500800A (en) Human fmo3 gene mutations and polymorphisms, and uses thereof
AU7336296A (en) Human hepatitis b virus dna
AU4860299A (en) (zap-3) tumor associated genes and their uses
AU1906599A (en) Pancreatic-derived factors, and uses related thereto

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase